Akari Therapeutics ADR (AKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AKTX | AMGN | VRTX | REGN | GILD |
| Company | Akari Therapeutics ADR | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 2.26 | 318.49 | 477.20 | 930.23 | 89.45 |
| High | 2.50 | 319.20 | 480.41 | 943.83 | 89.74 |
| Low | 2.25 | 314.88 | 475.05 | 930.23 | 88.45 |
| Last | 2.36 | 316.98 | 477.70 | 933.02 | 89.00 |
| Change | +0.09 | +1.29 | +5.79 | +4.12 | +0.22 |
| % Change | +4.16% | +0.41% | +1.23% | +0.44% | +0.25% |
| Volume | 12,400 | 1,604,300 | 1,019,700 | 547,700 | 5,734,900 |
| 20-Day Average Volume | 11,015 | 1,660,975 | 1,018,700 | 693,645 | 4,870,525 |
| Previous Close | 2.27 | 315.69 | 471.91 | 928.90 | 88.78 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.63 | 320.23 | 472.50 | 997.79 | 85.89 |
| 20-Day Raw Stochastic | 16.53% | 21.56% | 58.38% | 9.57% | 89.31% |
| 20-Day Relative Strength | 37.09% | 44.88% | 51.56% | 26.62% | 68.87% |
| Weighted Alpha | -43.84 | +17.74 | +29.89 | +8.47 | +25.21 |
| Today's Opinion | 40% Sell | 8% Buy | 40% Buy | 40% Sell | 100% Buy |
| Previous Opinion | 40% Sell | 8% Buy | 24% Buy | 40% Sell | 100% Buy |
| Last Month's Opinion | 40% Buy | 40% Buy | 24% Buy | 40% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +5.56% since 10/18/24 | -1.45% since 10/18/24 | -1.10% since 10/18/24 | -5.82% since 10/18/24 | +2.63% since 10/18/24 |
| Low | 2.10 on 10/22/24 | 313.63 on 10/24/24 | 464.78 on 10/23/24 | 919.42 on 10/22/24 | 85.60 on 10/22/24 |
| High | 2.50 on 10/25/24 | 321.80 on 10/21/24 | 487.88 on 10/21/24 | 991.23 on 10/21/24 | 89.74 on 10/25/24 |
| 1-Month | |||||
| %Chg | -25.17% since 09/25/24 | +1.32% since 09/25/24 | +3.45% since 09/25/24 | -9.52% since 09/25/24 | +8.26% since 09/25/24 |
| Low | 2.10 on 10/22/24 | 313.37 on 09/26/24 | 447.70 on 10/07/24 | 919.42 on 10/22/24 | 81.83 on 09/26/24 |
| High | 3.85 on 09/26/24 | 329.17 on 10/11/24 | 499.09 on 10/17/24 | 1,070.00 on 09/27/24 | 89.74 on 10/25/24 |
| 3-Month | |||||
| %Chg | -40.79% since 07/25/24 | -5.18% since 07/25/24 | -2.96% since 07/25/24 | -12.33% since 07/25/24 | +16.32% since 07/25/24 |
| Low | 2.10 on 10/22/24 | 306.59 on 08/07/24 | 447.70 on 10/07/24 | 919.42 on 10/22/24 | 72.43 on 08/12/24 |
| High | 4.40 on 07/26/24 | 340.89 on 08/01/24 | 510.64 on 08/01/24 | 1,211.20 on 08/27/24 | 89.74 on 10/25/24 |
| 6-Month | |||||
| %Chg | +98.70% since 04/25/24 | +17.67% since 04/25/24 | +20.12% since 04/25/24 | +4.75% since 04/25/24 | +36.36% since 04/25/24 |
| Low | 1.17 on 04/26/24 | 265.72 on 04/26/24 | 391.70 on 04/30/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
| High | 4.40 on 07/26/24 | 346.85 on 07/25/24 | 510.64 on 08/01/24 | 1,211.20 on 08/27/24 | 89.74 on 10/25/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 17,987 | 169,347,168 | 121,777,800 | 102,351,768 | 110,606,832 |
| Shares Outstanding, K | 7,924 | 536,435 | 258,053 | 110,186 | 1,245,853 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 27,116,000,000 |
| Annual Net Income | -10,010,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 5,665,000,000 |
| Last Quarter Sales | 0 | 8,388,000,000 | 2,645,600,000 | 3,547,100,000 | 6,954,000,000 |
| Last Quarter Net Income | -7,560,000 | 746,000,000 | -3,593,600,000 | 1,432,300,000 | 1,614,000,000 |
| 60-Month Beta | 0.93 | 0.61 | 0.40 | 0.12 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.00 on 08/19/24 | 4.97 on 08/06/24 | -12.83 on 08/01/24 | 11.56 on 08/01/24 | 2.01 on 08/08/24 |
| Latest Earnings Date | 05/06/24 | 10/30/24 | 11/04/24 | 10/31/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | N/A | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 08/16/24 | N/A | N/A | 09/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.93 | 0.00 | 24.50 | 18.56 |